146 related articles for article (PubMed ID: 29593284)
41. Secretory leukocyte protease inhibitor (SLPI), a multifunctional protein in the host defense response.
Majchrzak-Gorecka M; Majewski P; Grygier B; Murzyn K; Cichy J
Cytokine Growth Factor Rev; 2016 Apr; 28():79-93. PubMed ID: 26718149
[TBL] [Abstract][Full Text] [Related]
42. [Effects of secretory leukocyte protease inhibitor on expression of inflammation mediators in normal human bronchial epithelial cells induced by cigarette smoke extract].
Qu MY; Luo BL; Chen HM; Feng JT; Gu QH
Zhonghua Jie He He Hu Xi Za Zhi; 2008 May; 31(5):352-5. PubMed ID: 18953959
[TBL] [Abstract][Full Text] [Related]
43. Endogenous secretory leukocyte protease inhibitor inhibits microbial-induced monocyte activation.
Nugteren S; Simons-Oosterhuis Y; Menckeberg CL; Hulleman-van Haaften DH; Lindenbergh-Kortleve DJ; Samsom JN
Eur J Immunol; 2023 Feb; 53(2):e2249964. PubMed ID: 36480463
[TBL] [Abstract][Full Text] [Related]
44. The expression of secretory leukocyte protease inhibitor (SLPI) in the fallopian tube: SLPI protects the acrosome reaction of sperm from inhibitory effects of elastase.
Ota Y; Shimoya K; Zhang Q; Moriyama A; Chin R; Tenma K; Kimura T; Koyama M; Azuma C; Murata Y
Hum Reprod; 2002 Oct; 17(10):2517-22. PubMed ID: 12351521
[TBL] [Abstract][Full Text] [Related]
45. Increased expression of the secretory leukocyte proteinase inhibitor in Wegener's granulomatosis.
Ohlsson S; Falk R; Yang JJ; Ohlsson K; Segelmark M; Wieslander J
Clin Exp Immunol; 2003 Jan; 131(1):190-6. PubMed ID: 12519404
[TBL] [Abstract][Full Text] [Related]
46. SLPI and trappin-2 as therapeutic agents to target airway serine proteases in inflammatory lung diseases: current and future directions.
Zani ML; Tanga A; Saidi A; Serrano H; Dallet-Choisy S; Baranger K; Moreau T
Biochem Soc Trans; 2011 Oct; 39(5):1441-6. PubMed ID: 21936830
[TBL] [Abstract][Full Text] [Related]
47. Cleaved SLPI, a novel biomarker of chymase activity.
Belkowski SM; Masucci J; Mahan A; Kervinen J; Olson M; de Garavilla L; D'Andrea MR
Biol Chem; 2008 Sep; 389(9):1219-24. PubMed ID: 18713008
[TBL] [Abstract][Full Text] [Related]
48. Effect of the secretory leucocyte proteinase inhibitor (SLPI) on Candida albicans biological processes: a therapeutic alternative?
Curvelo JA; Barreto AL; Portela MB; Alviano DS; Holandino C; Souto-Padrón T; Soares RM
Arch Oral Biol; 2014 Sep; 59(9):928-37. PubMed ID: 24907522
[TBL] [Abstract][Full Text] [Related]
49. Secretory leukocyte protease inhibitor and lung inflammation in developing bronchopulmonary dysplasia.
Watterberg KL; Carmichael DF; Gerdes JS; Werner S; Backstrom C; Murphy S
J Pediatr; 1994 Aug; 125(2):264-9. PubMed ID: 7913723
[TBL] [Abstract][Full Text] [Related]
50. The expression and clinical significance of secretory leukocyte proteinase inhibitor (SLPI) in mammary carcinoma using bioinformatics analysis.
Xie W; Zhang H; Qin S; Zhang J; Fan X; Yin Y; Liang R; Long H; Yi W; Fu D; Ma C; Lv M; Yu F
Gene; 2019 Dec; 720():144088. PubMed ID: 31476404
[TBL] [Abstract][Full Text] [Related]
51. The phospholipid scramblases 1 and 4 are cellular receptors for the secretory leukocyte protease inhibitor and interact with CD4 at the plasma membrane.
Py B; Basmaciogullari S; Bouchet J; Zarka M; Moura IC; Benhamou M; Monteiro RC; Hocini H; Madrid R; Benichou S
PLoS One; 2009; 4(3):e5006. PubMed ID: 19333378
[TBL] [Abstract][Full Text] [Related]
52. Clobetasol down-regulates SLPI expression in U937 monocytoid cells.
Okumura N; Yoshida H; Kitagishi Y; Nishimura Y; Matsuda S
Int J Mol Med; 2012 Feb; 29(2):324-6. PubMed ID: 22076618
[TBL] [Abstract][Full Text] [Related]
53. Secretory leukocyte protease inhibitor regulates human periodontal ligament cell production of pro-inflammatory cytokines.
Svensson D; Aidoukovitch A; Anders E; Jönsson D; Nebel D; Nilsson BO
Inflamm Res; 2017 Sep; 66(9):823-831. PubMed ID: 28597116
[TBL] [Abstract][Full Text] [Related]
54. Release of neutrophil proteinase 4(3) and leukocyte elastase during phagocytosis and their interaction with proteinase inhibitors.
Bergenfeldt M; Axelsson L; Ohlsson K
Scand J Clin Lab Invest; 1992 Dec; 52(8):823-9. PubMed ID: 1362620
[TBL] [Abstract][Full Text] [Related]
55. Distribution of secretory leukoprotease inhibitor in the human nasal airway.
Lee CH; Igarashi Y; Hohman RJ; Kaulbach H; White MV; Kaliner MA
Am Rev Respir Dis; 1993 Mar; 147(3):710-6. PubMed ID: 8095126
[TBL] [Abstract][Full Text] [Related]
56. Inhibition by recombinant SLPI and half-SLPI (Asn55-Ala107) of elastase and cathepsin G activities: consequence for neutrophil-platelet cooperation.
Renesto P; Balloy V; Kamimura T; Masuda K; Imaizumi A; Chignard M
Br J Pharmacol; 1993 Apr; 108(4):1100-6. PubMed ID: 8097952
[TBL] [Abstract][Full Text] [Related]
57. Secretory leukocyte proteinase inhibitor is a major leukocyte elastase inhibitor in human neutrophils.
Sallenave JM; Si Tahar M; Cox G; Chignard M; Gauldie J
J Leukoc Biol; 1997 Jun; 61(6):695-702. PubMed ID: 9201260
[TBL] [Abstract][Full Text] [Related]
58. The secretory leukocyte protease inhibitor gene is a target of epidermal growth factor receptor action in endometrial epithelial cells.
Velarde MC; Parisek SI; Eason RR; Simmen FA; Simmen RC
J Endocrinol; 2005 Jan; 184(1):141-51. PubMed ID: 15642791
[TBL] [Abstract][Full Text] [Related]
59. The effect of immediate-hypersensitivity reactions on the level of SLPI, granulocyte elastase, alpha1-antitrypsin, and albumin in nasal secretions, by the method of unilateral antigen challenge.
Westin U; Lundberg E; Wihl JA; Ohlsson K
Allergy; 1999 Aug; 54(8):857-64. PubMed ID: 10485390
[TBL] [Abstract][Full Text] [Related]
60. Modulation of HIV Replication in Monocyte-Derived Macrophages (MDM) by Host Antiviral Factors Secretory Leukocyte Protease Inhibitor and Serpin Family C Member 1 Induced by Steroid Hormones.
Biswas S; Chen E; Gao Y; Lee S; Hewlett I; Devadas K
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
